A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab

Waller, CF; Vutikullird, A; Lawrence, TE; Shaw, A; Liu, MS; Baczkowski, M; Sharma, R; Barve, A; Goyal, P; Donnelly, C; Sengupta, N; Pennella, EJ

Waller, CF (reprint author), Univ Med Ctr Freiburg, Dept Haematol Oncol & Stem Cell Transplantat, Hugstetter Str 55, D-79106 Freiburg, Germany.; Waller, CF (reprint author), Univ Freiburg, Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018; 84 (10): 2336

Abstract

AimsTrastuzumab is a humanized monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2) oncoprotein and is an effective ther......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索